Health Canada must monitor doctors’ off-label drug prescriptions, warns a Senate committee. And lawmakers urged a crackdown on the illegal promotion of off-label uses by pharmaceutical sales reps: “We think it’s inexcusable”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
